High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial
Abstract Background People with multiple sclerosis have high risk of osteoporosis and fractures. A poor vitamin D status is a risk factor for MS, and vitamin D supplementation has been recommended both to prevent MS progression and to maintain bone health. Methods We assessed the effect of 20,000 IU...
Main Authors: | Trygve Holmøy, Jonas Christoffer Lindstrøm, Erik Fink Eriksen, Linn Hofsøy Steffensen, Margitta T. Kampman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12883-017-0851-0 |
Similar Items
-
Effectiveness of Vitamin D Supplementation in the Management of Multiple Sclerosis: A Systematic Review
by: Monika Berezowska, et al.
Published: (2019-03-01) -
Investigating the Safety and Therapeutic Potential of Vitamin D3 with Calcium Supplementation in Patients with Multiple Sclerosis
by: Kimball, Samantha
Published: (2011) -
Investigating the Safety and Therapeutic Potential of Vitamin D3 with Calcium Supplementation in Patients with Multiple Sclerosis
by: Kimball, Samantha
Published: (2011) -
Statistical, pathophysiological and clinical aspects of the relationship between multiple sclerosis and osteoporosis
by: Tomasz Grzegorski, et al.
Published: (2016-03-01) -
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
by: Egil Røsjø, et al.
Published: (2020-04-01)